Skip to main content
. Author manuscript; available in PMC: 2019 Dec 5.
Published in final edited form as: Gynecol Oncol. 2017 Aug 24;147(2):402–407. doi: 10.1016/j.ygyno.2017.08.015

Table 3.

Relationship of antitumor activity with archival FRα expression level.

FRα expression No. of patients CR PR ORR N (%) PFS (months) PFS 95% CI
Low 6 0 0 0 (0.0) 2.8 (1.3, 5.4)
Medium 5 0 1 1 (20.0) 3.9 (2.6, 12.7)
High 16 2 3 5 (31.3) 5.4 (2.8, −)
Overall 27 2 4 6 (22.2) 4.2 (2.8, 5.4)

CR, complete response; PR, partial response; ORR, objective response rate; PFS, progression-free survival; CI, confidence interval.